Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist ...
The common symptoms of a wheat or gluten allergy differ from gluten intolerances and sensitivities, as they often affect more ...
Almost half of Canadian households that have children with celiac disease are struggling to afford gluten-free foods, ...
The "Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region" report ...
Almost half of Canadian households that have children with celiac disease are struggling to afford gluten-free foods, ...
Celiac disease management varies across the globe, with significant disparities in disease awareness and resources in high- and lower-income countries.
Amlitelimab is under clinical development by Sanofi and currently in Phase II for Celiac Disease. According to GlobalData, Phase II drugs for Celiac Disease does not have sufficient historical data to ...
We’re all aware of the increased availability of gluten-free foods, but how much do you really know about why some peopl ...
The data indicate KAN-101 reduces multiple gluten induced symptoms and celiac-specific composite measures in a Phase 2 trial KAN-101 was safe and tolerated in individuals with celiac disease Celiac ...